Filing Details

Accession Number:
0001415889-22-005567
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-24 10:24:56
Reporting Period:
2022-05-23
Accepted Time:
2022-05-24 10:24:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818844 Virios Therapeutics Inc. VIRI Pharmaceutical Preparations (2834) 854314201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831127 Scott Gregory Duncan C/O Virios Therapeutics, Inc.
44 Milton Avenue
Alpharetta GA 30009
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-23 7,500 $4.52 32,461 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct